Is apoptosis a massive process in myelodysplastic syndromes?

Area of Science:

• Hematology
• Cell Biology
• Molecular Biology

Background:

• Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis and a high risk of transformation to acute myeloid leukemia.
• Increased apoptosis (programmed cell death) of hematopoietic precursors has been implicated in the pathogenesis of MDS, contributing to cytopenias.

Purpose of the Study:

• To investigate the prevalence and characteristics of apoptosis in bone marrow aspirates from patients with myelodysplastic syndromes (MDS).
• To evaluate the utility of the TUNEL technique and short-term bone marrow culture in detecting increased apoptosis in MDS.

Main Methods:

• Analysis of fresh bone marrow aspirates from 40 MDS cases using the TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) technique to detect DNA fragmentation.
• Re-analysis of apoptosis in a subset of cases with normal TUNEL findings after short-term (18-hour) bone marrow culture without apoptosis inducers, using morphological assessment and/or the TUNEL technique.

Main Results:

• No DNA laddering was observed in any cases.
• The TUNEL technique detected a moderate increase in apoptotic cells (2.5-5%) in 15% of fresh bone marrow samples.
• After short-term culture, increased apoptosis was detected in 4 out of 7 previously normal cases, predominantly affecting erythroblasts.
• The percentage of apoptotic cells remained below 40% in all analyzed samples.

Conclusions:

• Increased apoptosis can be detected in approximately half of myelodysplastic syndrome cases following short-term bone marrow culture.
• The study highlights the potential role of apoptosis in MDS pathogenesis and suggests further investigation into its relationship with cytopenias.
• The TUNEL technique and short-term culture are valuable tools for assessing apoptosis in MDS, particularly when initial analysis is inconclusive.